These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 25115718)
1. Positron emission tomography combined with computed tomography for diagnosis of synchronous tumors. Garcheva M; Zlatareva D; Gocheva L Klin Onkol; 2014; 27(4):283-6. PubMed ID: 25115718 [TBL] [Abstract][Full Text] [Related]
2. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT. Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699 [TBL] [Abstract][Full Text] [Related]
3. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers. Ilcheva M; Nikolova P; Hadzhiyska V; Mladenov K Neoplasma; 2022 Jul; 69(4):948-956. PubMed ID: 35471980 [TBL] [Abstract][Full Text] [Related]
4. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
5. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT. Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818 [TBL] [Abstract][Full Text] [Related]
6. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma. Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897 [TBL] [Abstract][Full Text] [Related]
7. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis. Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659 [TBL] [Abstract][Full Text] [Related]
8. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study. Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188 [TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma. Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652 [TBL] [Abstract][Full Text] [Related]
10. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma. Kitajima K; Suenaga Y; Sugimura K Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982 [TBL] [Abstract][Full Text] [Related]
11. Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma. Huang YT; Ravi Kumar AS Nucl Med Commun; 2012 May; 33(5):503-8. PubMed ID: 22262244 [TBL] [Abstract][Full Text] [Related]
12. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma. Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372 [TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143 [TBL] [Abstract][Full Text] [Related]
15. Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study. Flygare L; Al-Ubaedi A; Öhman W; Mo SJ Acta Radiol; 2020 Sep; 61(9):1196-1204. PubMed ID: 31902218 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822 [TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642 [TBL] [Abstract][Full Text] [Related]
18. ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature. Lauridsen JK; Rohde M; Thomassen A PET Clin; 2015 Jan; 10(1):75-88. PubMed ID: 25455881 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Wax MK; Myers LL; Gabalski EC; Husain S; Gona JM; Nabi H Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):703-7. PubMed ID: 12049568 [TBL] [Abstract][Full Text] [Related]
20. Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT. Derlin T; Clauditz TS; Quaas A; Habermann CR Clin Nucl Med; 2012 Oct; 37(10):e255-6. PubMed ID: 22899191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]